Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review-Reference-Cited by-同舟云学术

Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review

Author:

Hosseini Mina¹²,Habibi Zahra³,Hosseini Narges⁴,Abdoli Sina³,Rezaei Nima¹⁵⁶

Affiliation:

1. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

2. Department of Pharmaceutical Biotechnology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

3. School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

4. Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

5. Research Center for Immunodeficiencies (RCID), Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

6. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Funder

funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

Reference187 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献